Compare TTK HEALTHCARE with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE AJANTA PHARMA TTK HEALTHCARE/
AJANTA PHARMA
 
P/E (TTM) x 12.6 27.4 45.8% View Chart
P/BV x 1.8 7.6 24.0% View Chart
Dividend Yield % 0.8 0.5 182.9%  

Financials

 TTK HEALTHCARE   AJANTA PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
AJANTA PHARMA
Mar-19
TTK HEALTHCARE/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2151,422 85.4%   
Low Rs610898 68.0%   
Sales per share (Unadj.) Rs444.4233.5 190.3%  
Earnings per share (Unadj.) Rs17.244.0 39.2%  
Cash flow per share (Unadj.) Rs27.652.2 53.0%  
Dividends per share (Unadj.) Rs5.009.00 55.6%  
Dividend yield (eoy) %0.50.8 70.6%  
Book value per share (Unadj.) Rs177.9255.1 69.8%  
Shares outstanding (eoy) m14.1388.02 16.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.15.0 41.3%   
Avg P/E ratio x52.926.4 200.6%  
P/CF ratio (eoy) x33.022.2 148.5%  
Price / Book Value ratio x5.14.5 112.8%  
Dividend payout %29.020.5 141.6%   
Avg Mkt Cap Rs m12,894102,081 12.6%   
No. of employees `0002.36.8 34.0%   
Total wages/salary Rs m1,3074,307 30.3%   
Avg. sales/employee Rs Th2,715.73,022.6 89.8%   
Avg. wages/employee Rs Th565.3633.4 89.3%   
Avg. net profit/employee Rs Th105.4569.1 18.5%   
INCOME DATA
Net Sales Rs m6,27920,554 30.5%  
Other income Rs m78211 36.8%   
Total revenues Rs m6,35620,765 30.6%   
Gross profit Rs m4965,664 8.7%  
Depreciation Rs m147721 20.4%   
Interest Rs m3412 291.4%   
Profit before tax Rs m3935,143 7.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1491,273 11.7%   
Profit after tax Rs m2443,870 6.3%  
Gross profit margin %7.927.6 28.6%  
Effective tax rate %37.924.8 153.2%   
Net profit margin %3.918.8 20.6%  
BALANCE SHEET DATA
Current assets Rs m2,71711,812 23.0%   
Current liabilities Rs m1,5713,776 41.6%   
Net working cap to sales %18.339.1 46.7%  
Current ratio x1.73.1 55.3%  
Inventory Days Days3277 41.6%  
Debtors Days Days4782 57.2%  
Net fixed assets Rs m99114,398 6.9%   
Share capital Rs m141175 80.6%   
"Free" reserves Rs m2,37322,277 10.7%   
Net worth Rs m2,51422,452 11.2%   
Long term debt Rs m37 51.5%   
Total assets Rs m4,15826,962 15.4%  
Interest coverage x12.6444.3 2.8%   
Debt to equity ratio x00 460.0%  
Sales to assets ratio x1.50.8 198.1%   
Return on assets %6.714.4 46.4%  
Return on equity %9.717.2 56.2%  
Return on capital %16.923.0 73.8%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22510,682 2.1%   
Fx outflow Rs m712,102 3.4%   
Net fx Rs m1548,580 1.8%   
CASH FLOW
From Operations Rs m1733,748 4.6%  
From Investments Rs m97-2,228 -4.3%  
From Financial Activity Rs m-307-1,475 20.8%  
Net Cashflow Rs m-3845 -83.4%  

Share Holding

Indian Promoters % 65.4 73.8 88.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 1.6 238.7%  
FIIs % 5.2 7.6 68.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.0 151.8%  
Shareholders   12,723 20,968 60.7%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SHASUN PHARMA  WYETH  ABBOTT INDIA  SUVEN LIFE SCIENCES  DR. REDDYS LAB  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 11, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS